Kuur Therapeutics announces first patients dosed with allogeneic CAR-NKT cell therapy

This article was originally published here

“This is an important day, as the initiation and dosing of the first patients in the ANCHOR phase 1 clinical study marks the first time that patients have

The post Kuur Therapeutics announces first patients dosed with allogeneic CAR-NKT cell therapy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply